Cargando…
Korean Society of Infectious Diseases/National Evidence-based Healthcare Collaborating Agency Recommendations for Anti-SARS-CoV-2 Monoclonal Antibody Treatment of Patients with COVID-19
Neutralizing antibodies targeted at the receptor-binding domain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein have been developed and now under evaluation in clinical trials. The US Food and Drug Administration currently issued emergency use authorizations for neutral...
Autores principales: | Kim, Sun Bean, Kim, Jimin, Huh, Kyungmin, Choi, Won Suk, Kim, Yae-Jean, Joo, Eun-Jeong, Kim, Youn Jeong, Yoon, Young Kyung, Heo, Jung Yeon, Seo, Yu Bin, Jeong, Su Jin, Yu, Su-Yeon, Peck, Kyong Ran, Choi, Miyoung, Yeom, Joon Sup |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258293/ https://www.ncbi.nlm.nih.gov/pubmed/34216134 http://dx.doi.org/10.3947/ic.2021.0304 |
Ejemplares similares
-
Revised Korean Society of Infectious Diseases/National Evidence-based Healthcarea Collaborating Agency Guidelines on the Treatment of Patients with COVID-19
por: Kim, Sun Bean, et al.
Publicado: (2021) -
Interim Guidelines on Antiviral Therapy for COVID-19
por: Kim, Sun Bean, et al.
Publicado: (2020) -
Clinical efficacy and safety of interferon (Type I and Type III) therapy in patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials
por: Ryoo, Seungeun, et al.
Publicado: (2023) -
Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: a systematic review and meta-analysis
por: Yu, Su-Yeon, et al.
Publicado: (2022) -
Clinical efficacy of inhaled corticosteroids in patients with coronavirus disease 2019: A living review and meta-analysis
por: Yu, Su-Yeon, et al.
Publicado: (2023)